Ved fortsat langtidsbehandling var 47, 4% af patienterne fri for toniske- kloniske anfald i mindst 6 måneder og 31, 5% var fri for toniske- kloniske anfald i mindst 1 år.
With continued long-term treatment, 47.4% of the patients were free of tonic-clonic seizures for at least 6 months and 31.5% were free of tonic-clonic seizures for at least 1 year.